325 related articles for article (PubMed ID: 16987838)
1. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
[TBL] [Abstract][Full Text] [Related]
2. Phototherapy in systemic sclerosis: Review.
Chaowattanapanit S; Choonhakarn C; Foocharoen C; Julanon N
Photodermatol Photoimmunol Photomed; 2017 Nov; 33(6):296-305. PubMed ID: 28703365
[TBL] [Abstract][Full Text] [Related]
3. Innovative antifibrotic therapies in systemic sclerosis.
Beyer C; Distler O; Distler JH
Curr Opin Rheumatol; 2012 May; 24(3):274-80. PubMed ID: 22450392
[TBL] [Abstract][Full Text] [Related]
4. Utility of phototherapy in patients with systemic sclerosis: Systematic review.
Miziołek B; Tworek M; Łapczyńska E; Tekielak A; Kochanowska J; Polak K; Bergler-Czop B
Dermatol Ther; 2022 Jun; 35(6):e15478. PubMed ID: 35357072
[TBL] [Abstract][Full Text] [Related]
5. Phototherapy and photochemotherapy of sclerosing skin diseases.
Brenner M; Herzinger T; Berking C; Plewig G; Degitz K
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):157-65. PubMed ID: 15888135
[TBL] [Abstract][Full Text] [Related]
6. Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures.
Kitamura Y; Namikawa H; Hayashi S; Yoshida T; Suzuki T; Hamasaki Y; Yamazaki S; Hatamochi A
Arch Dermatol Res; 2009 Aug; 301(7):507-13. PubMed ID: 19343355
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and therapeutic problems of scleroderma].
Pogorzelska-Antkowiak A; Antkowiak R
Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
[TBL] [Abstract][Full Text] [Related]
9. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review.
Kroft EB; Berkhof NJ; van de Kerkhof PC; Gerritsen RM; de Jong EM
J Am Acad Dermatol; 2008 Dec; 59(6):1017-30. PubMed ID: 18835066
[TBL] [Abstract][Full Text] [Related]
11. Rate of acute adverse events for narrow-band UVB and Psoralen-UVA phototherapy.
Martin JA; Laube S; Edwards C; Gambles B; Anstey AV
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):68-72. PubMed ID: 17523927
[TBL] [Abstract][Full Text] [Related]
12. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
13. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
Pereira N; Santiago F; Oliveira H; Figueiredo A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and consequences of fibrosis in systemic sclerosis.
Denton CP; Black CM; Abraham DJ
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):134-44. PubMed ID: 16932673
[TBL] [Abstract][Full Text] [Related]
15. The mechanisms of action of phototherapy in the treatment of the most common dermatoses.
Bulat V; Situm M; Dediol I; Ljubicić I; Bradić L
Coll Antropol; 2011 Sep; 35 Suppl 2():147-51. PubMed ID: 22220423
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy in the age of biologics.
Walker D; Jacobe H
Semin Cutan Med Surg; 2011 Dec; 30(4):190-8. PubMed ID: 22123416
[TBL] [Abstract][Full Text] [Related]
17. Criteria to select molecular targets for anti-fibrotic therapy.
Distler JH; Distler O
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v12-3. PubMed ID: 18784127
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of systemic sclerosis with topical PUVA.
Morita A; Sakakibara S; Sakakibara N; Yamauchi R; Tsuji T
J Rheumatol; 1995 Dec; 22(12):2361-5. PubMed ID: 8835578
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural changes induced in cutaneous collagen by ultraviolet-A1 and psoralen plus ultraviolet A therapy in systemic sclerosis.
Sakakibara N; Sugano S; Morita A
J Dermatol; 2008 Feb; 35(2):63-9. PubMed ID: 18271800
[TBL] [Abstract][Full Text] [Related]
20. [Ultraviolet A-I phototherapy for skin diseases].
Polderman MC; Pavel S; Vermeer BJ; Wintzen M
Ned Tijdschr Geneeskd; 1999 May; 143(18):931-4. PubMed ID: 10368707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
